Infections in allogeneic bone marrow transplant recipients.
Remarkable strides have been made in the management of infectious complications after bone marrow transplantation. Improved understanding of patterns of infection, the introduction of new antimicrobials, the advent of cytokines to enhance immune recovery, the development of better strategies to control graft-versus-host disease, and the availability of more accurate and rapid diagnostic assays have all contributed to reducing the morbidity and mortality from infection after allogeneic marrow transplantation.
Wingard
J R
JR
Department of Medicine, Emory University School of Medicine, Atlanta, GA.
D001424:Bacterial Infections / Q000209:etiology* / Q000517:prevention & control; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control; D006561:Herpes Simplex / Q000209:etiology / Q000517:prevention & control; D006562:Herpes Zoster / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D009181:Mycoses / Q000209:etiology* / Q000517:prevention & control; D014777:Virus Diseases / Q000209:etiology* / Q000517:prevention & control